Nuvilex (PMCB)
(Delayed Data from NSDQ)
$2.05 USD
+0.12 (6.22%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $1.92 -0.13 (-6.34%) 6:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Nuvilex Inc falls in the month of April .
All items in Millions except EPS data.
4/30/24 | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 9 | 6 | 4 | 4 | 4 |
Income After Depreciation & Amortization | -9 | -6 | -4 | -4 | -4 |
Non-Operating Income | 9 | 2 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 0 | -4 | -4 | -4 | -4 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 0 | -4 | -4 | -4 | -4 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 0 | -4 | -4 | -4 | -4 |
Depreciation Footnote | 4/30/24 | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | -6 | -4 | -4 | -4 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -9 | -6 | -4 | -4 | -4 |
Earnings Per Share Data | 4/30/24 | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 |
---|---|---|---|---|---|
Average Shares | NA | 19.49 | 15.52 | 1.45 | 0.95 |
Diluted EPS Before Non-Recurring Items | -99,999.00 | -0.22 | -0.27 | -2.45 | 0.00 |
Diluted Net EPS (GAAP) | -1.80 | -0.22 | -0.27 | -2.45 | 0.00 |
Fiscal Year end for Nuvilex Inc falls in the month of April .
All items in Millions except EPS data.
7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3.16 | 1.87 | 1.41 | 2.07 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -3.16 | -1.87 | -1.41 | -2.07 |
Non-Operating Income | NA | 6.09 | 1.25 | 4.20 | -1.11 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 1.35 | -0.62 | 2.79 | -3.18 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 1.35 | -0.62 | 2.79 | -3.18 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 1.35 | -0.62 | 2.79 | -3.18 |
Earnings Per Share Data | 7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 8.61 | 8.77 | 12.60 |
Diluted EPS Before Non-Recurring Items | -99,999.00 | -99,999.00 | -0.65 | -0.64 | -0.28 |
Diluted Net EPS (GAAP) | -99,999.00 | -0.61 | -0.65 | -0.26 | -0.28 |